Processa Pharmaceuticals, Inc. (PCSA) Shareholders’ equity 2016–2022
Processa Pharmaceuticals, Inc. (PCSA) shareholders’ equity at each fiscal year-end, per SEC filings.
$7.5MFY2022 · since FY2016: -$2.3M → $7.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $7.5M | -70.7% |
| FY2021 | $25.5M | — |
| FY2016 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice